Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cellgebra logo — New strategies for target and biomarker discovery

Cellgebra

New strategies for target and biomarker discovery

Founded 2020 Ireland Ireland 1 employees Biotechnology

General Information

Company Name Cellgebra
Founded Year 2020
Location Ireland Ireland
Employees 1
Industries Biotechnology
Social

BounceWatch is an independent company data service, not affiliated with Cellgebra. To contact Cellgebra, visit cellgebra.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Cellgebra

Cellgebra is a biotechnology startup based in Ireland that aims to revolutionize cancer clinical trials with their innovative approach to target and biomarker discovery. Their slogan "New strategies for target and biomarker discovery" encapsulates their commitment to improving the success rate of cancer clinical trials, which currently stands at less than 5%. The company's groundbreaking method involves leveraging a large scale mathematical model of cell type-specific signaling networks in cancer to integrate information about the status of thousands of DNA and RNA markers. This enables the accurate prediction of patient response, potentially doubling the success rate of clinical trials. Additionally, their model applications extend to predicting drug resistance mechanisms and identifying new targets for cancer treatment. With their forward-thinking approach, Cellgebra not only demonstrates potential for significant impact in the biotechnology industry but also presents an attractive opportunity for venture capital investment.

Taxonomy: cancer clinical trials, biomarker discovery, DNA markers, RNA markers, drug resistance mechanisms, target identification, cellular networks, cell type specific, signalling networks, data-driven computational models, cancer drug discovery

No funding data available for Cellgebra yet.

Cellgebra Alternatives & Competitors

Cellgebra vs
CytoReason
CytoReason Israel

The First Cell-Centered Computational Model of Human Disease

Series B
104 employees
Biotechnology
Cellgebra vs
WittGen Biotechnologies
WittGen Biotechnologies United States

Decode cancer's cellular secrets, driving therapeutic breakthroughs from targets to markers beyond c...

Seed
9 employees
Biotechnology, Information Technology
Cellgebra vs
Myllia Biotechnology
Myllia Biotechnology Austria

High-content CRISPR screening in primary human cells for unbiased target discovery and AI-driven fou...

24 employees
Biotechnology

FAQ About Cellgebra

New strategies for target and biomarker discovery
Cellgebra was founded in 2020.
Cellgebra is headquartered in Ireland.
Cellgebra operates in Biotechnology. Its work centres on cancer clinical trials, biomarker discovery, DNA markers and RNA markers.
Cellgebra has approximately 1 employees.
Top alternatives and competitors to Cellgebra include CytoReason, WittGen Biotechnologies, Myllia Biotechnology, Envisagenics, Inspirna, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellgebra and CytoReason are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cellgebra, https://bouncewatch.com/company/cellgebra, updated 28 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes